128 related articles for article (PubMed ID: 17491697)
1. Effect of losartan on the mRNA expressions of MT3-MMP and TIMP-2 in diabetic kidneys.
Ding HL; Xu MT; Guo Y; Chen L; Zhang SL; Li F; Fu ZZ
Rev Diabet Stud; 2005; 2(4):216-20. PubMed ID: 17491697
[TBL] [Abstract][Full Text] [Related]
2. [Effects of losartan on MT3-MMP and TIMP2 mRNA expressions in diabetic rat kidney].
Wan X; Huang HH; Li JG
Di Yi Jun Yi Da Xue Xue Bao; 2004 Dec; 24(12):1391-4. PubMed ID: 15604066
[TBL] [Abstract][Full Text] [Related]
3. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
[TBL] [Abstract][Full Text] [Related]
4. Effect of angiotensin II receptor blocker on glucose-induced mRNA expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rat mesangial cells.
Ding HL; Guo Y; Xu MT; Li HY; Fu ZZ
Chin Med J (Engl); 2007 Nov; 120(21):1886-9. PubMed ID: 18067760
[TBL] [Abstract][Full Text] [Related]
5. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
[TBL] [Abstract][Full Text] [Related]
6. Losartan alleviates renal fibrosis by down-regulating HIF-1α and up-regulating MMP-9/TIMP-1 in rats with 5/6 nephrectomy.
Fu W; Wang Y; Jin Z; Wang H; Cheng W; Zhou H; Yin P; Peng W
Ren Fail; 2012; 34(10):1297-304. PubMed ID: 23006043
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of doxycycline, losartan, and their combination on the expression of matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, and collagen remodeling in the noninfarcted myocardium after acute myocardial infarction in rats].
Zhang P; Yang YJ; Chen X; Ruan YM; Zhou YW; Tian Y; Chen ZJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):53-61. PubMed ID: 15782494
[TBL] [Abstract][Full Text] [Related]
8. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
Ciechanowicz A
Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
[TBL] [Abstract][Full Text] [Related]
9. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
[TBL] [Abstract][Full Text] [Related]
10. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.
Bolbrinker J; Markovic S; Wehland M; Melenhorst WB; van Goor H; Kreutz R
J Pharmacol Exp Ther; 2006 Jan; 316(1):8-16. PubMed ID: 16166267
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta1 and Smad4 signaling pathway down-regulates renal extracellular matrix degradation in diabetic rats.
Yang Q; Xie RJ; Yang T; Fang L; Han B; Zhang GZ; Cheng ML
Chin Med Sci J; 2007 Dec; 22(4):243-9. PubMed ID: 18246672
[TBL] [Abstract][Full Text] [Related]
12. [Protective effects of hyperbaric oxygen treatment on kidney cells of type 2 diabetic rats].
Nie WJ; Cao XQ; Shao GQ
Sheng Li Xue Bao; 2014 Apr; 66(2):186-94. PubMed ID: 24777409
[TBL] [Abstract][Full Text] [Related]
13. [Effects of puerarin on renal function, expressions of MMP-2 and TIMP-2 in diabetic rats].
Duan HJ; Liu SX; Zhang YJ; Liu QJ; He N; Li YM
Yao Xue Xue Bao; 2004 Jul; 39(7):481-5. PubMed ID: 15493832
[TBL] [Abstract][Full Text] [Related]
14. [Effects of losartan on the levels of angiotensin II and its type-1 receptor in diabetic rat kidney].
Wu W; Ding HL; Chen LH; Fu ZZ
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1742-4. PubMed ID: 17259110
[TBL] [Abstract][Full Text] [Related]
15. [Losartan downregulates the expression of transforming growth factor beta type I and type II receptors in kidney of diabetic rat].
Guo ZX; Qiu MC
Zhonghua Nei Ke Za Zhi; 2003 Jun; 42(6):403-8. PubMed ID: 12895325
[TBL] [Abstract][Full Text] [Related]
16. [The effect of inhibiting nuclear factor-kappa B on the diabetic nephropathy].
Ding H; Li F; Xu M; Deng Y; Deng Q; Zhu Z; Cheng H; Fu Z; Wang Y
Zhonghua Nei Ke Za Zhi; 2002 Sep; 41(9):605-9. PubMed ID: 12421493
[TBL] [Abstract][Full Text] [Related]
17. Effect of a specific endothelin receptor A antagonist and an angiotensin-converting enzyme inhibitor on glomerular mRNA levels for extracellular matrix components, metalloproteinases (MMP) and a tissue inhibitor of MMP in aminonucleoside nephrosis.
Ebihara I; Nakamura T; Tomino Y; Koide H
Nephrol Dial Transplant; 1997 May; 12(5):1001-6. PubMed ID: 9175058
[TBL] [Abstract][Full Text] [Related]
18. H
Li Y; Li L; Zeng O; Liu JM; Yang J
Ren Fail; 2017 Nov; 39(1):265-272. PubMed ID: 27882817
[TBL] [Abstract][Full Text] [Related]
19. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
[TBL] [Abstract][Full Text] [Related]
20. [Effects of doxycycline on the expression of matrix metalloproteinase and tissue inhibitor of MMP in myocardium after acute myocardial infarction: an animal experiment with rats].
Zhang P; Yang YJ; Chen X; Ruan YM; Zhou YW; Tian Y; Chen ZJ
Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1288-93. PubMed ID: 15387968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
